Ranolazine-Reference-Cited by-同舟云学术

Ranolazine

Published:2013-01 Issue:1 Volume:73 Page:55-73
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Keating Gillian M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-012-0005-z.pdf

Reference88 articles.

1. Lopez-Sendon J, Purcell H, Camici P, et al. Chronic stable angina guidelines: is there an emerging international consensus? Br J Cardiol. 2012;19(Suppl. 2):S2–11.

2. Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503–16.

3. Chaitman BR, Skettino SL, Parker JO, et al. Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina. J Am Coll Cardiol. 2004;43(8):1375–82.

4. European Medicines Agency. Ranexa (ranolazine): EU summary of product characteristics. 2011. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000805/human_med_001009.jsp&mid=WC0b01ac058001d124 . Accessed 12 Sep 2012.

5. Keating GM. Ranolazine: a review of its use in chronic stable angina pectoris. Drugs. 2008;68(17):2483–503.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-ischemic and pleiotropic effects of ranolazine in chronic coronary syndromes;The American Journal of the Medical Sciences;2023-12

2. Cardiovascular Effects of Ranolazine and the Scope for Translational Research: A Current Review of Literature;Frontiers in Cardiovascular Drug Discovery;2022-11-09

3. Pharmacology of Ranolazine versus Common Cardiovascular Drugs in Patients with Early Diastolic Dysfunction Induced by Anthracyclines or Nonanthracycline Chemotherapeutics: A Phase 2b Minitrial;Journal of Pharmacology and Experimental Therapeutics;2019-05-17

4. Management of Chronic Stable Angina;Critical Care Nursing Clinics of North America;2017-12

5. A literature review to evaluate the economic value of ranolazine for the symptomatic treatment of chronic angina pectoris;International Journal of Cardiology;2016-05